- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Mankind pharma Launches new critical care division
Through Saviour Mankind, the company will also Introduce certain ‘1st time in India’ products which will provide additional armamentarium for Doctors and complement their efforts in tackling the challenges posed by increasing rates of antimicrobial resistance in India.
New Delhi: Mankind Pharma, one of the leading Pharmaceutical companies in India has announced its foraying into critical care.The company has launched Saviour Mankind, a dedicated division for life-saving injectables. The division has commenced operation with products ranging from Anti-infectives to Stroke & Trauma Management. Through Saviour Mankind, the company will also Introduce...
New Delhi: Mankind Pharma, one of the leading Pharmaceutical companies in India has announced its foraying into critical care.
The company has launched Saviour Mankind, a dedicated division for life-saving injectables. The division has commenced operation with products ranging from Anti-infectives to Stroke & Trauma Management.
Through Saviour Mankind, the company will also Introduce certain '1st time in India' products which will provide additional armamentarium for Doctors and complement their efforts in tackling the challenges posed by increasing rates of antimicrobial resistance in India.
With this new division, Mankind Pharma is all set to partner with Doctors and ICU staff in their everyday practice. Frequent stock-outs of critical-care products during COVID-19 pandemic is said to have urged Mankind Pharma to step-in and support the medical fraternity with products that are vital in resuscitation of critically ill patients.
Also Read:Mankind Pharma forays into pet food category
Speaking on the launch Mr. Sheetal Arora, CEO, Mankind Pharma, stated, "Since inception, Mankind Pharma has pioneered the philosophy of 'Serving Life' and the launch of Saviour Mankind is one more step in the same direction. Through this division, we hope to partner with our Doctors in saving lives of critically ill patients. Mankind Pharma stands strong with our fellow Indians and facilitating easy access to such medicines will prove life-saving for Multitude of Patients."
Critical care range medicines have witnessed huge demand in the country.
With the launch, Mankind Pharma aspires to aid the community in leading a healthy life by formulating, developing, commercializing & delivering affordable and accessible medicines that satisfy urgent medical needs of patients.
Having begun its journey in 1995, Mankind Pharma operates in 34 overseas destinations leveraging 16,000 happy employees and is one of the leading Pharma Companies in India. Having made a name for itself by establishing one of the most robust presence in each and every nook and corner of country.
Doctor of Pharmacy
Dr. Divya Colin, a Doctor of Pharmacy Graduate with extensive experience in clinical and hospital settings and confidently equipped with diagnostic and therapeutic skills. She also has spread out exposure to Oncology Departments in Mysore Medical College and Research Institute as Oncology Pharmacist. Currently she is building a career in clinical research and clinical data management. She has been a part of Medical Dialogue since January 2022.